Liminatus Pharma (LIMN) Stock Chart & Stock Price History $1.29 -0.30 (-18.87%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsFDA EventsSEC FilingsShort InterestTrendsBuy This Stock Liminatus Pharma Stock Price Performance The Liminatus Pharma (LIMN) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has decreased 67.51%, reflecting recent market activity. As of the latest close, Liminatus Pharma traded at $1.59 with a market cap of $41.36 million and volume of 624,934 shares. Receive LIMN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Liminatus Pharma and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-35.50%1 Month Performance-67.51% LIMN Stock Chart for Thursday, September, 18, 2025 LIMN Chart by TradingView Liminatus Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/17/2025$1.79$1.59-11.17%$1.78$1.58624,934 shs$41.36 million09/16/2025$1.85$1.79-3.24%$1.87$1.75344,144 shs$46.56 million09/15/2025$2.00$1.85-7.50%$1.98$1.81482,221 shs$48.13 million09/12/2025$2.08$2.00-3.85%$2.16$1.98650,467 shs$52.03 million09/11/2025$2.03$2.08+2.46%$2.11$1.821.86 million shs$54.10 million09/10/2025$2.45$2.03-17.14%$2.44$2.001.57 million shs$52.80 million09/09/2025$2.31$2.45+6.06%$2.52$2.351.78 million shs$63.73 million09/08/2025$2.67$2.31-13.48%$2.60$2.30485,693 shs$60.08 million09/05/2025$2.83$2.67-5.65%$2.90$2.67236,364 shs$69.45 million09/04/2025$2.98$2.83-5.03%$3.09$2.83363,705 shs$73.61 million Get the Latest News and Ratings for LIMN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Liminatus Pharma and its competitors with MarketBeat's FREE daily newsletter. 09/03/2025$2.99$2.98-0.33%$3.03$2.82354,208 shs$77.51 million09/02/2025$2.71$2.99+10.33%$3.04$2.771.33 million shs$77.79 million09/01/2025$2.71$2.71$2.78$2.61970,953 shs$70.49 million08/29/2025$2.76$2.71-1.81%$2.78$2.61970,953 shs$70.49 million08/28/2025$3.02$2.76-8.61%$3.04$2.72528,406 shs$71.79 million08/27/2025$3.25$3.02-7.08%$3.30$2.99645,888 shs$78.57 million08/26/2025$3.40$3.25-4.41%$3.42$3.15920,145 shs$84.53 million08/25/2025$3.41$3.40-0.29%$3.60$2.931.62 million shs$88.43 million08/22/2025$2.78$3.41+22.66%$4.06$3.0935.51 million shs$88.69 million08/21/2025$3.34$2.78-16.77%$3.31$2.531.27 million shs$72.32 million08/20/2025$3.86$3.34-13.47%$3.87$3.28464,438 shs$86.87 million08/19/2025$3.97$3.86-2.77%$4.00$3.77244,711 shs$100.40 million08/18/2025$4.00$3.97-0.75%$4.12$3.94191,926 shs$103.26 million Related Companies GENFIT Stock Chart Tiziana Life Sciences Stock Chart MediWound Stock Chart Entrada Therapeutics Stock Chart SELLAS Life Sciences Group Stock Chart Heron Therapeutics Stock Chart Eupraxia Pharmaceuticals Stock Chart Journey Medical Stock Chart Innate Pharma Stock Chart C4 Therapeutics Stock Chart Receive LIMN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Liminatus Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LIMN) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liminatus Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liminatus Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LIMN Stock Alerts